Giant Biogene Holding Co. (SEHK:2367) Price Target Decreased by 12.21% to 50.31

Average one-year price target for Giant Biogene (SEHK:2367) was revised to HK$50.31, down 12.21% from the prior HK$57.31 estimate dated Feb 21, 2026. The new target is the mean of multiple analyst price targets. The cut signals weaker analyst expectations and potential downside relative to the prior consensus, but is likely to have limited broader market impact.

Analysis

Average one-year price target for Giant Biogene (SEHK:2367) was revised to HK$50.31, down 12.21% from the prior HK$57.31 estimate dated Feb 21, 2026. The new target is the mean of multiple analyst price targets. The cut signals weaker analyst expectations and potential downside relative to the prior consensus, but is likely to have limited broader market impact.